Work

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

Year: 2016

Type: article

Source: Current Cancer Drug Targets

DOI: 10.2174/1568009616666160331124759

Authors: Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler, Yiyu Zou

Institutions: Yeshiva University, Jingzhou Central Hospital, Albert Einstein College of Medicine

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy

OpenAlex ID: W2317087529

FWCI: 0.173

Cites:

Cited by: 3

Related to: 10